Results 121 to 130 of about 644,240 (320)

Optimised accelerated solvent extraction of hexahydro‐1, 3, 5‐trinitro‐1, 3, 5 triazine (RDX) from polymer bonded explosives [PDF]

open access: yes, 2018
An Accelerated Solvent Extraction (ASE) method was developed and optimised to extract hexahydro‐1,3,5‐trinitro‐1,3,5‐triazine (RDX) from a polyurethane matrix. The ASE method development was benchmarked against Soxhlet extraction with a view to improving
Coulon, Frederic   +4 more
core   +2 more sources

Identification of functional and diverse circulating cancer‐associated fibroblasts in metastatic castration‐naïve prostate cancer patients

open access: yesMolecular Oncology, EarlyView.
Cancer‐associated fibroblasts (CAFs) promote cancer growth, invasion (metastasis), and drug resistance. Here, we identified functional and diverse circulating CAFs (cCAFs) in patients with metastatic prostate cancer (mPCa). cCAFs were found in higher numbers and were functional and diverse in mPCa patients versus healthy individuals, suggesting their ...
Richell Booijink   +6 more
wiley   +1 more source

Comparative Evaluation of Protease Extraction from Leaves of Syzygium polyanthum

open access: yesIndonesian Journal of Chemistry, 2019
In this study, the comparison of four extraction methods for protease from the leaves of Syzygium polyanthum was evaluated. The methods include sodium phosphate buffer, 1-methyl-8-oxyquinolinium betaine (QB) solvent based extraction, hydrogen-bond ...
Noorhafiza Yahya   +6 more
doaj   +1 more source

Surfaceome: a new era in the discovery of immune evasion mechanisms of circulating tumor cells

open access: yesMolecular Oncology, EarlyView.
In the era of immunotherapies, many patients either do not respond or eventually develop resistance. We propose to pave the way for proteomic analysis of surface‐expressed proteins called surfaceome, of circulating tumor cells. This approach seeks to identify immune evasion mechanisms and discover potential therapeutic targets. Circulating tumor cells (
Doryan Masmoudi   +3 more
wiley   +1 more source

Uncertainty-Informed Screening for Safer Solvents Used in the Synthesis of Perovskite via Language Models [PDF]

open access: yesarXiv
The challenge of accurately predicting toxicity of industrial solvents used in perovskite synthesis is a necessary undertaking but is limited by a lack of a targeted and structured toxicity data. This paper presents a novel framework that combines an automated data extraction using language models, and an uncertainty-informed prediction model to fill ...
arxiv  

Dispersive liquid-liquid microextraction-gas chromatography-mass spectrometric determination of polycylic aromatic hydrocarbons in water [PDF]

open access: yes, 2011
In this work, a sample preparation method based on dispersive liquid-liquid microextraction (DLLME) coupled with gas chromatography-mass spectrometry (GC-MS) was developed for the extraction of polycyclic aromatic hydrocarbons (PAHs), namely phenanthrene
Sharef A., Sarra Younes
core  

Clinical applications of next‐generation sequencing‐based ctDNA analyses in breast cancer: defining treatment targets and dynamic changes during disease progression

open access: yesMolecular Oncology, EarlyView.
Circulating tumor DNA (ctDNA) offers a possibility for different applications in early and late stage breast cancer management. In early breast cancer tumor informed approaches are increasingly used for detecting molecular residual disease (MRD) and early recurrence. In advanced stage, ctDNA provides a possibility for monitoring disease progression and
Eva Valentina Klocker   +14 more
wiley   +1 more source

Circulating tumor cells: advancing personalized therapy in small cell lung cancer patients

open access: yesMolecular Oncology, EarlyView.
Small cell lung cancer (SCLC) is an aggressive form of lung cancer that spreads rapidly to secondary sites such as the brain and liver. Cancer cells circulating in the blood, “circulating tumor cells” (CTCs), have demonstrated prognostic value in SCLC, and evaluating biomarkers on CTCs could guide treatment decisions such as for PARP inhibitors ...
Prajwol Shrestha   +6 more
wiley   +1 more source

Home - About - Disclaimer - Privacy